Qiagen
QGENPre-clinicalQIAGEN operates as a Sample to Insight company, providing integrated solutions that transform biological samples into valuable molecular insights. With a focus on molecular diagnostics and life sciences research, the company serves clinical laboratories, academic institutions, pharmaceutical and biotechnology companies worldwide. QIAGEN's product portfolio spans the entire sample-to-insight workflow, from sample collection and preparation to assay development, automation, and data analysis. The company is publicly traded on NASDAQ under the ticker QGEN and is headquartered in the Netherlands.
QGEN · Stock Price
Historical price data
AI Company Overview
QIAGEN operates as a Sample to Insight company, providing integrated solutions that transform biological samples into valuable molecular insights. With a focus on molecular diagnostics and life sciences research, the company serves clinical laboratories, academic institutions, pharmaceutical and biotechnology companies worldwide. QIAGEN's product portfolio spans the entire sample-to-insight workflow, from sample collection and preparation to assay development, automation, and data analysis. The company is publicly traded on NASDAQ under the ticker QGEN and is headquartered in the Netherlands.
Technology Platform
Comprehensive Sample to Insight platform providing integrated solutions from sample preparation through assay development, automation, and data analysis for molecular diagnostics and life sciences research applications.
Opportunities
Risk Factors
Competitive Landscape
QIAGEN competes with major players including Thermo Fisher Scientific, Roche Diagnostics, Abbott, and Illumina across different product categories. The company differentiates through its integrated Sample to Insight approach and focus on comprehensive workflow solutions rather than standalone instruments, though faces pressure from larger, more diversified competitors.
Company Info
Trading
Contact
Therapeutic Areas
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile